Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in Major Spinal Surgery
NCT02902380Completed
- Sponsor
- Yonsei University
- Start
- Sep 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of dexmedetomidine in spinal stenosis, sponsored by Yonsei University. Primary endpoint: Stress hormone. Started Sep 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
spinal stenosis
Beyond the preview
Go deeper on NCT02902380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02902380.